Characterization of toxoplasma gondii-Specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 13, 2001, Pages 3228-3232

  Feron, Eric J ^a   Klaren, Vincent N A ^b   Wierenga, Eddy A ^c   Verjans, Georges M G M ^a,d   Kijlstra, Aize ^b,c,e  

^a ROTTERDAM EYE HOSPITAL   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; HLA ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; RECEPTORS, ANTIGEN, T CELL, ALPHA BETA;

ADULT; AGED; ANIMAL; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; T LYMPHOCYTE; TOXOPLASMA; TOXOPLASMOSIS; UVEITIS; VITREOUS BODY;

ADULT; AGED; ANIMAL; ANTIGENS, CD3; ANTIGENS, CD4; CYTOKINES; FEMALE; HLA ANTIGENS; HUMAN; MALE; MIDDLE AGE; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; UVEITIS; VITREOUS BODY;

EID: 0035651008     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kean DH. Clinical toxoplasmosis: 50 years. Trans R Soc Trop Med Hyg. 1972;66:549-571.
2. Frenkel JK. Pathophysiology of toxoplasmosis. Parasitol Today. 1988;4:273-278.
3. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998;11:569-588.
4. Hunter CA, Remington JS. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis. 1994;170:1057-1067.
5. Nussenblatt RB. Ocular toxoplasmosis. In: Nussenblatt RB, Palestine AG. Uveitis: Fundamentals and Clinical Practice. Chicago: Year Book Medical; 1989:336-354.
6. Rutzen AR, Smith RE, Rao NA. Recent advances in the understanding of ocular toxoplasmosis. Curr Opin Ophthalmol. 1994;5:3-9.
7. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp Parasitol. 1994;70:217-229.
8. Toledo de Abreu M, Belfort R Jr, Matheus PC, Santos LM, Scheinberg MA. T-lymphocyte subsets in the aqueous humor and peripheral blood of patients with acute untreated uveitis. Am J Ophthalmol. 1984;98:62-65.
9. Deschenes J, Char DH, Freeman W, Nozik R, Garovoy M. Uveitis: lymphocyte subpopulation studies. Trans Ophthalmol Soc UK. 1986;105:246-251.
10. Wang XC, Norose K, Yano A, Ohta K, Segawa K. Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis. Curr Eye Res. 1995;14:425-433.
11. de Boer JH, Verhagen C, Bruinenberg M, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996;21:650-658.
12. + T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993;342:646-650.
13. + T cells in corneas of herpetic stromal keratitis patients. J Infect Dis. 1998;177:484-488.
14. Hughes HPA, van Knapen F, Atkinson HJ, Balfour AH, Lee DL. A new soluble antigen preparation of Toxoplasma gondii and its use in serological diagnosis. Clin Exp Immunol. 1982;49:239-246.
15. Van der Lelij A, Rothova A, Stilma JS, Hoekzema R, Kijlstra A. Cell-mediated immunity against human retinal extract, S-antigen, and interphotoreceptor retinoid binding protein in onchocercal chorioretinopathy. Invest Ophthalmol Vis Sci. 1990;10:2031-2036.
16. Verjans GMGM, Klaren VNA, Leirisalo-Repo M, et al. Characterization of the T cell receptor Vα and Vβ gene repertoire in synovial fluid of HLA-B27 positive reactive arthritis patients. Clin Rheumatol. 1996;15:91-96.
17. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier W, Kapsenberg ML. Human atopic-specific types 1 and 2 T helper cell clones. J Immunol. 1991;147:2942-2949.
18. Saavedra R, Herion P. Human T-cell clones against Toxoplasma gondii: production of interferon-γ, interleukin-2 and strain cross-reactivity. Parasitol Res. 1991;77:379-385.
19. + cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. J Immunol. 1993;151:2024-2031.
20. Daubener W, Mackenzie C, Hadding U. Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones. Immunology. 1995;86:79-84.
21. + monoclonal T cells and macrophages results in killing of trophozoites. J Immunol. 1988;140:3580-3588.
22. Sklenar I, Jones TC, Alkan S, Erb P. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis. 1986;153:315-324.
23. Beaman MH, Wong S-Y, Remington JS. Cytokines, Toxoplasma and intracellular parasitism. Immunol Rev. 1992;127:97-117.
24. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516-518.
25. Sharma SD, Hofflin JM, Remington JS. In vivo recombinant interleukin-2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J Immunol. 1985;135:4160-4163.
26. Hunter CA, Roberts CW, Alexander J. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol. 1992;22:2317-2322.
27. Roberts CW, Ferguson DJP, Jebbari H, et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun. 1996;64:897-904.
28. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J Immunol. 1992;148:1792-1796.
29. Gazzinelli RT, Eltoum I, Wynn TA, Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 1993;151:3672-3681.
30. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659-2665.
31. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. J Exp Med. 1989;169:59-72.
32. Bessieres MH, Swierczynski B, Cassaing S, et al. Role of IFN-γ, TNF-α, IL-4 and IL-10 in the regulation of experimental Toxoplasma gondii infection. J Eukaryot Microbiol. 1997;44:87-89.
33. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467-471.